Bellevue Group AG Cuts Position in Privia Health Group, Inc. (NASDAQ:PRVA)

Bellevue Group AG lessened its stake in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 10.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 953,164 shares of the company's stock after selling 106,007 shares during the quarter. Bellevue Group AG owned approximately 0.79% of Privia Health Group worth $18,634,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. First Horizon Advisors Inc. lifted its holdings in Privia Health Group by 53.8% during the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company's stock worth $35,000 after purchasing an additional 632 shares in the last quarter. EverSource Wealth Advisors LLC grew its stake in Privia Health Group by 7,833.3% during the fourth quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company's stock valued at $47,000 after acquiring an additional 2,350 shares in the last quarter. Financial Management Professionals Inc. bought a new stake in Privia Health Group during the 4th quarter worth approximately $51,000. Quadrant Capital Group LLC lifted its stake in Privia Health Group by 11.8% in the 4th quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company's stock worth $95,000 after purchasing an additional 511 shares in the last quarter. Finally, Nisa Investment Advisors LLC grew its position in shares of Privia Health Group by 185.7% during the 4th quarter. Nisa Investment Advisors LLC now owns 4,999 shares of the company's stock valued at $98,000 after purchasing an additional 3,249 shares in the last quarter. Hedge funds and other institutional investors own 94.48% of the company's stock.

Privia Health Group Trading Up 1.4 %

Shares of PRVA stock traded up $0.34 during trading hours on Friday, reaching $25.41. The company's stock had a trading volume of 753,432 shares, compared to its average volume of 767,387. The stock has a market capitalization of $3.08 billion, a P/E ratio of 254.13, a P/E/G ratio of 3.47 and a beta of 0.87. The firm's fifty day simple moving average is $23.39 and its 200 day simple moving average is $22.22. Privia Health Group, Inc. has a one year low of $15.92 and a one year high of $26.09.

Analyst Ratings Changes

A number of brokerages have weighed in on PRVA. Barclays upped their target price on Privia Health Group from $21.00 to $23.00 and gave the stock an "equal weight" rating in a research note on Thursday, April 10th. Piper Sandler raised their price objective on Privia Health Group from $25.00 to $40.00 and gave the company an "overweight" rating in a report on Friday, February 28th. Robert W. Baird boosted their target price on Privia Health Group from $24.00 to $26.00 and gave the stock an "outperform" rating in a research report on Tuesday, April 15th. Truist Financial increased their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the company a "buy" rating in a research report on Thursday, April 10th. Finally, Needham & Company LLC restated a "buy" rating and issued a $30.00 price objective on shares of Privia Health Group in a report on Thursday, April 10th. One analyst has rated the stock with a hold rating, eleven have given a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, Privia Health Group has a consensus rating of "Buy" and an average target price of $27.38.

Insider Activity at Privia Health Group

In related news, CEO Parth Mehrotra sold 15,100 shares of the business's stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total transaction of $352,283.00. Following the transaction, the chief executive officer now owns 454,281 shares in the company, valued at $10,598,375.73. The trade was a 3.22 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO David Mountcastle sold 3,445 shares of the firm's stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $23.33, for a total transaction of $80,371.85. Following the completion of the sale, the chief financial officer now owns 176,231 shares of the company's stock, valued at $4,111,469.23. This trade represents a 1.92 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 34,484 shares of company stock worth $799,163 over the last quarter. Corporate insiders own 10.70% of the company's stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.